Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota. // Drug Metabolism and Disposition. – URL: https://www.sciencedirect.com/science/article/pii/S0090955626007105?dgcid=rss_sd_all
Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota. Drug Metabolism and Disposition. https://www.sciencedirect.com/science/article/pii/S0090955626007105?dgcid=rss_sd_all
“Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota.” Drug Metabolism and Disposition.
@article{article43464,
title = {Pharmacokinetics, Mass Balance, and Biotransformation of a Novel Dual-Target Neuroprotectant [14C]Loberamisal (Y-3) in Humans: Clues from Rat Studies, Mechanistic Roles of UDP-Glucuronosyltransferase and Gut Microbiota},
journal = {Drug Metabolism and Disposition},
url = {https://www.sciencedirect.com/science/article/pii/S0090955626007105?dgcid=rss_sd_all}
}